2019 oncology drugs in pipeline — survey

14 December 2018 - pCODR is again undertaking its periodic survey to facilitate consistent and systematic data collection from participating ...

Read more →

CADTH publishes initial recommendation for Tagrisso

5 November 2018 - CADTH has published its initial recommendation on the use of osimertinib mesylate for the first-line treatment ...

Read more →

CADTH publishes initial recommendation for Lenvima

5 November 2018 - CADTH has published its initial recommendation on the use of lenvatinib mesylate in combination with everolimus ...

Read more →

Hundreds of cancer patients received partial doses of medication

16 August 2018 - Hundreds of cancer patients in Canada did not receive the full dose of three highly concentrated ...

Read more →

Whistler woman forced to fundraise for cancer drugs

21 June 2018 - Joni Denroche staying positive after insurance fails to cover needed treatment. ...

Read more →

Same cancer, worse results and twice the cost in the US

1 June 2018 - Americans paid twice as much as Canadians for health care, but they didn't get twice the ...

Read more →

Give paediatric cancer sufferers the help they need

21 May 2018 - Her necklace has 650 beads, one for each medical procedure she has been through. ...

Read more →

This 12-year-old leukaemia survivor is fighting for equal access to medicine for all Canadians

17 May 2018 - Helena Kirk, a 12-year-old leukaemia survivor, helped spearhead a proposal to the Minister of Health with support ...

Read more →

Ontario NDP promise take-home cancer drug coverage ahead of election

30 April 2018 - NDP Leader Andrea Horwath is promising universal access to take-home cancer drugs if her party wins ...

Read more →

Governments must speed up access to approved cancer drugs

16 April 2018 - Strides in cancer research have increased survival rates and provided a better quality of life for ...

Read more →

The relative importance of clinical, economic, patient values and feasibility criteria in cancer drug reimbursement in Canada: a revealed preferences analysis of recommendations of the pan-Canadian Oncology Drug Review 2011–2017

20 January 2018 - Most Canadian provinces and territories rely on the pan-Canadian Oncology Drug Review to provide recommendations regarding public ...

Read more →

Digby, N.S., dad obtains high-priced drug to fight rare cancer

25 February 2018 - 'My immediate response is a big sigh of relief. It's a huge stress lifted,' says Jordan Morgan. ...

Read more →

Quebec and New Brunswick become first provinces to provide public funding of Ibrance for the first-line treatment of metastatic breast cancer

15 February 2018 - Since Ibrance received Health Canada marketing authorisation in March 2016, Canadian women living with metastatic breast cancer ...

Read more →

Pricey drug could help Digby dad fighting rare cancer

25 January 2018 - Jordan Morgan diagnosed with undifferentiated cell sarcoma 4 years ago. ...

Read more →

A tale of 2 friends with breast cancer; 1 has coverage for costly drug, the other forced to pay

20 January 2018 - Two women say their cases challenge commonly held belief that B.C. is the gold standard for cancer ...

Read more →